How can scientific methods be used to evaluate the efficacy and safety of traditional remedies?

Jan 8, 2021 ... However, clinical information with respect to its utilization in infection caused by ESBL producers is limited. The aim of this study was a ... ... ESBL-E in adults increases with patients' age. In this retrospective observational study, enrolling 547 ESBL-E colonized elderly patients with community ... hospitals among the many bacterial species of ESBL producers mentioned above, in this study we ... Testing; 16th Informational Supplement. CLSI document ... Apr 16, 2019 ... coli isolates. -Conclusion: In this study, 3 K. pneumoniae isolates simultaneously carried ESBL, AmpC, and carbapenemase genes. Up-to-date ... An Abattoir-Based Study on the Prevalence of Salmonella Fecal Carriage and ESBL Related Antimicrobial Resistance from Culled Adult Dairy Cows in Wuhan, China. The incidence of ESBL-producing E. coli bacteremia rose during the study period. By multiple logistic analysis, reported antibiotic use in the previous week was ... May 5, 2017 ... No clinical information was available about the patients from whom the cultures were taken. The identity and antimicrobial drug susceptibility ... Oct 17, 2018 ... The current study indicated that non ESBL producing K. pneumoniae isolates were found to be highly susceptible to Carbapenems (imipenem. The presenting study investigated bloodstream infections due to ESBL–EK in our center over a three and one-half years period. A total of 94 strains were ... In this study we aimed to investigate in vitro activity of meropenem, ciprofloxacine and amikacin against ESBL-producing and non-producing blood isolates.